Literature DB >> 24990271

Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) setting.

Jennifer K Harrison1, Patricia Fearon, Anna H Noel-Storr, Rupert McShane, David J Stott, Terry J Quinn.   

Abstract

BACKGROUND: The IQCODE (Informant Questionnaire for Cognitive Decline in the Elderly) is a commonly used questionnaire based tool that uses collateral information to assess for cognitive decline and dementia. Brief tools that can be used for dementia "screening" or "triage" may have particular utility in primary care / general practice healthcare settings but only if they have suitable test accuracy.A synthesis of the available data regarding IQCODE accuracy in a primary care setting should help inform cognitive assessment strategies for clinical practice; research and policy.
OBJECTIVES: We sought to describe the accuracy of IQCODE (the index test) against a clinical diagnosis of dementia (the reference standard). In this review we focus on those studies conducted in a primary care (general practice) setting. SEARCH
METHODS: A search was performed in the following sources on the 28th of January 2013: ALOIS (Cochrane Dementia and Cognitive Improvement Group), MEDLINE (Ovid SP), EMBASE (Ovid SP), PsycINFO (Ovid SP), BIOSIS (Ovid SP), ISI Web of Science and Conference Proceedings (ISI Web of Knowledge), CINHAL (EBSCOhost) and LILACs (BIREME). We also searched sources specific to diagnostic test accuracy: MEDION (Universities of Maastricht and Leuven); DARE (York University); HTA Database (Health Technology Assessments Database via The Cochrane Library) and ARIF (Birmingham University). We developed a sensitive search strategy; search terms were designed to cover key concepts using several different approaches run in parallel and included terms relating to cognitive tests, cognitive screening and dementia. We used standardized database subject headings such as MeSH terms (in MEDLINE) and other standardized headings (controlled vocabulary) in other databases, as appropriate. SELECTION CRITERIA: We selected those studies performed in primary care settings, which included (not necessarily exclusively) IQCODE to assess for the presence of dementia and where dementia diagnosis was confirmed with clinical assessment. For the "primary care" setting, we included those healthcare settings where unselected patients, present for initial, non-specialist assessment of memory or non-memory related symptoms; often with a view to onward referral for more definitive assessment. DATA COLLECTION AND ANALYSIS: We screened all titles generated by electronic database searches and abstracts of all potentially relevant studies were reviewed. Full papers were assessed for eligibility and data extracted by two independent assessors. Quality assessment (risk of bias and applicability) was determined using the QUADAS-2 tool. Reporting quality was determined using the STARDdem extension to the STARD tool. MAIN
RESULTS: From 71 papers describing IQCODE test accuracy, we included 1 paper, representing data from 230 individuals (n=16 [7%] with dementia). The paper described those patients consulting a primary care service who self-identified as Japanese-American. Dementia diagnosis was made using Benson & Cummings criteria and the IQCODE was recorded as part of a longer interview with the informant.IQCODE accuracy was assessed at various test thresholds, with a "trade-off" between sensitivity and specificity across these cutpoints. At an IQCODE threshold of 3.2 sensitivity: 100%, specificity: 76%; for IQCODE 3.7 sensitivity: 75%, specificity: 98%.Applying the QUADAS-2 assessments, the study was at high risk of bias in all categories. In particular degree of blinding was unclear and not all participants were included in the final analysis. AUTHORS'
CONCLUSIONS: It is not possible to give definitive guidance on the test accuracy of IQCODE for the diagnosis of dementia in a primary care setting based on the single study identified. We are surprised by the lack of research using the IQCODE in primary care as this is, arguably, the most appropriate setting for targeted case finding of those with undiagnosed dementia in order to maximise opportunities to intervene and provide support for the individual and their carers.

Entities:  

Mesh:

Year:  2014        PMID: 24990271     DOI: 10.1002/14651858.CD010771.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  19 in total

1.  The short-term and long-term relationship between delirium and cognitive trajectory in older surgical patients.

Authors:  Sharon K Inouye; Edward R Marcantonio; Cyrus M Kosar; Douglas Tommet; Eva M Schmitt; Thomas G Travison; Jane S Saczynski; Long H Ngo; David C Alsop; Richard N Jones
Journal:  Alzheimers Dement       Date:  2016-04-18       Impact factor: 21.566

Review 2.  18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Authors:  Gabriel Martínez; Robin Wm Vernooij; Paulina Fuentes Padilla; Javier Zamora; Leon Flicker; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2017-11-22

Review 3.  18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Authors:  Gabriel Martínez; Robin Wm Vernooij; Paulina Fuentes Padilla; Javier Zamora; Leon Flicker; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2017-11-22

Review 4.  Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settings.

Authors:  Jennifer K Harrison; David J Stott; Rupert McShane; Anna H Noel-Storr; Rhiannon S Swann-Price; Terry J Quinn
Journal:  Cochrane Database Syst Rev       Date:  2016-11-21

Review 5.  18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Authors:  Gabriel Martínez; Robin Wm Vernooij; Paulina Fuentes Padilla; Javier Zamora; Xavier Bonfill Cosp; Leon Flicker
Journal:  Cochrane Database Syst Rev       Date:  2017-11-22

6.  Accuracy of the Informant Questionnaire on Cognitive Decline in the Elderly for Detecting Preexisting Dementia in Transient Ischemic Attack and Stroke: A Population-Based Study.

Authors:  Astrid C van Nieuwkerk; Sarah T Pendlebury; Peter M Rothwell
Journal:  Stroke       Date:  2021-03-08       Impact factor: 7.914

7.  Mini-Cog for the detection of dementia within a community setting.

Authors:  Bruce A Fage; Calvin Ch Chan; Sudeep S Gill; Anna H Noel-Storr; Nathan Herrmann; Nadja Smailagic; Vasilis Nikolaou; Dallas P Seitz
Journal:  Cochrane Database Syst Rev       Date:  2021-07-14

8.  Mini-Cog for the detection of dementia within a primary care setting.

Authors:  Dallas P Seitz; Calvin Ch Chan; Hailey T Newton; Sudeep S Gill; Nathan Herrmann; Nadja Smailagic; Vasilis Nikolaou; Bruce A Fage
Journal:  Cochrane Database Syst Rev       Date:  2021-07-14

9.  Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within a secondary care setting.

Authors:  Jennifer K Burton; Patricia Fearon; Anna H Noel-Storr; Rupert McShane; David J Stott; Terry J Quinn
Journal:  Cochrane Database Syst Rev       Date:  2021-07-19

10.  Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early detection of dementia across a variety of healthcare settings.

Authors:  Jennifer K Burton; David J Stott; Rupert McShane; Anna H Noel-Storr; Rhiannon S Swann-Price; Terry J Quinn
Journal:  Cochrane Database Syst Rev       Date:  2021-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.